Naproxen

萘普生

Report date: 2025/12/18 17:46:41
NME

Base Information

Drug NameNaproxen
Drug Alias NameNaixanEC-NaprosynNaprosynRS-3650PL-3100 +[8] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPolyarticular Juvenile Idiopathic ArthritisSolid tumoursSoft Tissue Injuries +[23] 
Global Approved IndicationsPainDysmenorrheaTendinopathy +[9] 
Approved Indications in ChinaOsteoarthritisGoutArthritis, Rheumatoid +[4] 
Original Approved Country/TerritoryUnited States
Original Approved Date1976/03/11
Country/TerritoryCanadaUnited StatesGermany +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAtnahs Pharma
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityBayer AGAtnahs Pharma Us Ltd +[5] 
Inactive CompaniesTargeted Medical PharmaSandozGlaxosmithkline Plc +[10] 
Active IndicationsPolyarticular Juvenile Idiopathic ArthritisSoft Tissue InjuriesPain +[13] 
Inactive IndicationsSolid tumoursLow Back PainAcute Pain +[10] 

Other Information

ATC CodeG02CC02M01AE02M02AA12
Related LinksN/A